Logo for NeuroScientific Biopharmaceuticals Limited

NeuroScientific Biopharmaceuticals Investor Relations Material

Latest events

Logo for NeuroScientific Biopharmaceuticals

Q1 2025 TU

27 Oct, 2024
Logo for NeuroScientific Biopharmaceuticals

H2 2024

29 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from NeuroScientific Biopharmaceuticals Limited

Access all reports
NeuroScientific Biopharmaceuticals Limited is a biotechnology company focused on researching and developing therapies for neurodegenerative diseases and neurotrauma. The company’s work centers on novel peptide-based treatments aimed at conditions such as Alzheimer’s disease, multiple sclerosis, and other neurological disorders that involve degeneration or damage to nerve cells. The company is headquartered in Perth, Australia, and its shares are listed on the ASX.